Evidence map›Paper›PMID 40155698›Full record

ArticleScientific reports2025

Antimicrobial resistance and genomic characteristics of Campylobacter spp. From Australian meat chickens with A follow up investigation.

Nikki Owiredu, Soo Sum Lean, Marc Stegger, Hui San Allison, Kylie Hewson, Sue Sharpe, Anthony Pavic, Kittitat Lugsomya, David Jordan, David J Hampson and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nikki OwireduCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia.
Soo Sum LeanCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia.
Marc SteggerCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia.
Hui San AllisonCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia.
Kylie HewsonAustralian Chicken Meat Federation, North Sydney, NSW, North Sydney, Australia.
Sue SharpeBirling Avian Laboratories, Bringelly, NSW, Australia.
Anthony PavicBirling Avian Laboratories, Bringelly, NSW, Australia.
Kittitat LugsomyaSchool of Medical, Molecular, and Forensic Sciences, Murdoch University, Perth, Australia.
David JordanCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia.
David J HampsonCentre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia.
Sam Abraham *Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia. S.abraham@murdoch.edu.au.
Rebecca Abraham *Centre for Biosecurity and One Health, Harry Butler Institute, Murdoch University, Perth, Australia. R.abraham@murdoch.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing resistance of bacteria to antimicrobials is a major threat to public health. This study investigates the prevalence of antimicrobial resistance, both phenotypic and genotypic, among Campylobacter isolates from Australian meat chickens in 2022, as a follow up to investigate trends since the last national surveillance undertaken in 2016. Isolates (n = 186) were obtained at slaughter from 200 pooled cecal samples taken from 1,000 meat chickens. The majority of C. jejuni (68.7%) and C. coli (88.9%) isolates were susceptible to all the antibiotics that were tested, and no multi-drug resistance was found. Resistance to ciprofloxacin (fluoroquinolone) was detected in 24.4% of the C. jejuni and 3.2% of the C. coli isolates. Whole genome sequencing revealed a diverse range of sequence types (STs). These included 32 previously reported STs for C. jejuni and 13 for C. coli, as well as four and seven previously undescribed STs for each species, respectively. The STs containing fluoroquinolone-resistant isolates were ST2083, ST10130, ST2895, ST7323, ST2398, and ST1078 for C. jejuni, and ST860 and ST894 for C. coli. Although fluoroquinolones are not used in animal production in Australia, resistance amongst C. jejuni isolates was high (24.4%). This finding emphasizes the need for enhanced surveillance and regular sampling along the food chain to understand the source of the isolates and to mitigate risks of antimicrobial resistance to protect public health.

Indexed as

Anti-Bacterial AgentsCampylobacterCampylobacter InfectionsChickensDrug Resistance, BacterialGenome, BacterialMeatPoultry DiseasesAnimalsAustraliaCampylobacter jejuniCiprofloxacinDrug Resistance, Multiple, BacterialFollow-Up StudiesMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsCiprofloxacinAntimicrobial resistanceCampylobacter coliCampylobacter jejuniChickenFood safetyWhole genome sequencing

Identifiers

PMID40155698
PMCPMC11953255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.